Carbofuran poisoning detected by mass spectrometry of butyrylcholinesterase adduct in human serum

Journal of Applied Toxicology

Volumn 29, Issue 2, 2009, Pages 149-155

  Li, He ^a   Ricordel, Ivan ^b   Tong, Larry ^a   Schopfer, Lawrence M ^a   Baud, Frédéric ^c   Mégarbane, Bruno ^c   Maury, Eric ^d   Masson, Patrick ^e   Lockridge, Oksana ^a,f  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b Centre Universitaire des Saints Pères   (France)

^c INSERM   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e CENTRE DE RECHERCHES   (France)

^f NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Butyrylcholinesterase; Carbamate; Carbofuran; Human plasma; Multiple reaction monitoring; Pesticide

Indexed keywords

CARBOFURAN; CHOLINESTERASE; PROCAINAMIDE; SEPHAROSE; TRYPSIN;

ARTICLE; CARBAMOYLATION; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME PURIFICATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMICIDE; HUMAN; INTOXICATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DENATURATION; SERODIAGNOSIS; SUICIDE;

BINDING SITES; BUTYRYLCHOLINESTERASE; CARBOFURAN; CHOLINESTERASE INHIBITORS; FEMALE; HALF-LIFE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MASS SPECTROMETRY; MIDDLE AGED; MOLECULAR STRUCTURE; PROTEIN BINDING; SERUM; TRYPSIN;

EID: 62849127598     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1392     Document Type: Article

References (18)

1. Barr DB, Barr JR, Maggio VL, Whitehead RD, Jr, Sadowski MA, Whyatt RM, Needham LL. 2002. A multi-analyte method for the quantification of contemporary pesticides in human serum and plasma using high-resolution mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 778: 99-111.
2. Dulaurent S, Gaulier JM, Baudel JL, Fardet L, Maury E, Lachatre G. 2008. Hair analysis to document non-fatal pesticide intoxication cases. Forensic Sci. Int. 176: 72-75.
3. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95.
4. Fidder A, Hulst AG, Noort D, de Ruiter R, van der Schans MJ, Benschop HP, Langenberg JP. 2002. Retrospective detection of exposure to organophosphorus anti-cholinesterases: mass spectrometric analysis of phosphylated human butyrylcholinesterase. Chem. Res. Toxicol. 15: 582-590.
5. Grunwald J, Marcus D, Papier Y, Raveh L, Pittel Z, Ashani Y. 1997. Large-scale purification and long-term stability of human butyrylcholinesterase: a potential bioscavenger drug. J. Biochem. Biophys. Meth. 34: 123-135.
6. Gupta RC. 1994. Carbofuran toxicity. J. Toxicol. Environ. Hlth 43: 383-418.
7. Karnovsky MJ, Roots L. 1964. A 'direct-coloring' thiocholine method for cholinesterases. J. Histochem. Cytochem. 12: 219-221.
8. Lockridge O, La Du BN. 1978. Comparison of atypical and usual human serum cholinesterase. Purification, number of active sites, substrate affinity, and turnover number. J. Biol. Chem. 253: 361-366.
9. Lockridge O, Schopfer LM, Winger G, Woods JH. 2005. Large scale purification of butyrylcholinesterase from human plasma suitable for injection into monkeys; a potential new therapeutic for protection against cocaine and nerve agent toxicity. J. Med. CBR Def. 3.
10. Main AR. 1979. Mode of action of anticholinesterases. Pharmac. Ther. 6: 579-628.
11. Masson P. 1989. A naturally occurring molecular form of human plasma cholinesterase is an albumin conjugate. Biochim. Biophys. Acta 998: 258-266.
12. Petropoulou SS, Gikas E, Tsarbopoulos A, Siskos PA. 2006a. Gas chromatographic-tandem mass spectrometric method for the quantitation of carbofuran, carbaryl and their main metabolites in applicators' urine. J. Chromatogr. A 1108: 99-110.
13. Petropoulou SS, Tsarbopoulos A, Siskos PA. 2006b. Determination of carbofuran, carbaryl and their main metabolites in plasma samples of agricultural populations using gas chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 385: 1444-1456.
14. Reiner E. 1971. Spontaneous reactivation of phosphorylated and carbamylated cholinesterases. Bull. WHO 44: 109-112.
15. Sun J, Lynn BC. 2007. Development of a MALDI-TOF-MS method to identify and quantify butyrylcholinesterase inhibition resulting from exposure to organophosphate and carbamate pesticides. J. Am. Soc. Mass Spectrom. 18: 698-706.
16. Tsuge K, Seto Y. 2006. Detection of human butyrylcholinesterase-nerve gas adducts by liquid chromatography-mass spectrometric analysis after in gel chymotryptic digestion. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 838: 21-30.
17. Weinstock M, Groner E. 2008. Rational design of a drug for Alzheimer's disease with cholinesterase inhibitory and neuroprotective activity. Chem. Biol. Interact.
18. Wetherell JR, French MC. 1991. A comparison of the decarbamoylation rates of physostigmine-inhibited plasma and red cell cholinesterases of man with other species. Biochem. Pharmacol. 42: 515-520.